Myofiber degeneration in autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD) (LGMD1B)
- PMID: 17107595
- PMCID: PMC8095783
- DOI: 10.1111/j.1750-3639.2006.00028.x
Myofiber degeneration in autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD) (LGMD1B)
Abstract
Autosomal dominant Emery-Dreifuss muscular dystrophy is caused by mutations in the LMNA gene that code for the nuclear membrane protein lamin A/C. We investigated skeletal muscle fibers from several muscles for cytoplasmic degenerative changes in three patients with genetically confirmed Emery-Dreifuss muscular dystrophy. Methods included quantitative light and electron microscopy and PCR-based mutational analysis.
Results: The degenerative pathway was characterized by the gradual replacement of individual myofibers by connective tissue. Early stages of degeneration typically involved only a segment of the cross-sectional area of a myofiber. Intermediate stages consisted of myofiber shrinkage due to "shedding" of peripheral cytoplasmic portions into the endomysial space, and fragmentation of the myofibers by interposed collagen fibrils. Empty basement membrane sheaths surrounded by abundant deposits of extracellular matrix marked the end stage of the degenerative process. The nuclear number-to-cytoplasmic area in myofibers of one patient increased with increasing cross-sectional area, suggesting that satellite cell fusion with myofibers may have compensated for myofiber shrinkage. The pattern of degeneration described herein differs from muscular dystrophies with plasma membrane defects (dystrophinopathy, dysferlinopathy) and explains the frequently found absence of highly elevated serum creatine kinase levels in autosomal dominant Emery-Dreifuss muscular dystrophy.
Figures





Similar articles
-
Nuclear changes in skeletal muscle extend to satellite cells in autosomal dominant Emery-Dreifuss muscular dystrophy/limb-girdle muscular dystrophy 1B.Neuromuscul Disord. 2009 Jan;19(1):29-36. doi: 10.1016/j.nmd.2008.09.018. Epub 2008 Dec 12. Neuromuscul Disord. 2009. PMID: 19070492
-
Selective muscle involvement on magnetic resonance imaging in autosomal dominant Emery-Dreifuss muscular dystrophy.Neuropediatrics. 2002 Feb;33(1):10-4. doi: 10.1055/s-2002-23593. Neuropediatrics. 2002. PMID: 11930270
-
Autosomal dominant Emery-Dreifuss muscular dystrophy caused by a mutation in the lamin A/C gene identified by exome sequencing: a case report.BMC Pediatr. 2022 Oct 17;22(1):601. doi: 10.1186/s12887-022-03662-y. BMC Pediatr. 2022. PMID: 36253810 Free PMC article.
-
Clinical aspects of Emery-Dreifuss muscular dystrophy.Nucleus. 2018 Jan 1;9(1):268-274. doi: 10.1080/19491034.2018.1462635. Nucleus. 2018. PMID: 29633897 Free PMC article. Review.
-
Emery-Dreifuss muscular dystrophy.Curr Neurol Neurosci Rep. 2007 Jan;7(1):78-83. doi: 10.1007/s11910-007-0025-3. Curr Neurol Neurosci Rep. 2007. PMID: 17217858 Review.
Cited by
-
Myonuclear degeneration in LMNA null mice.Brain Pathol. 2008 Jul;18(3):338-43. doi: 10.1111/j.1750-3639.2008.00123.x. Epub 2008 Mar 26. Brain Pathol. 2008. PMID: 18371185 Free PMC article.
-
Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy.J Cell Biol. 2009 Jan 12;184(1):31-44. doi: 10.1083/jcb.200811035. Epub 2009 Jan 5. J Cell Biol. 2009. PMID: 19124654 Free PMC article.
-
Ankrd2 in Mechanotransduction and Oxidative Stress Response in Skeletal Muscle: New Cues for the Pathogenesis of Muscular Laminopathies.Oxid Med Cell Longev. 2019 Jul 24;2019:7318796. doi: 10.1155/2019/7318796. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31428229 Free PMC article. Review.
-
Human iPSC-Derived Muscle Cells as a New Model for Investigation of EDMD1 Pathogenesis.Int J Mol Sci. 2025 Feb 12;26(4):1539. doi: 10.3390/ijms26041539. Int J Mol Sci. 2025. PMID: 40004006 Free PMC article.
-
Mechanotransduction, nuclear architecture and epigenetics in Emery Dreifuss Muscular Dystrophy: tous pour un, un pour tous.Nucleus. 2018 Jan 1;9(1):276-290. doi: 10.1080/19491034.2018.1460044. Nucleus. 2018. PMID: 29619865 Free PMC article. Review.
References
-
- Ben Yaou BR, Muchir A, Arimura T, Massart C, Demay L, Richard P, Bonne G (2005) Genetics of laminopathies. Novartis Found Symp 264:81–97. - PubMed
-
- Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery‐Dreifuss muscular dystrophy. Nat Genet 21:285–288. - PubMed
-
- Bonne G, Mercuri E, Muchir A, Urtizberea A, Becane HM, Recan D, Merlini L, Wehnert M, Boor R, Reuner U, Vorgerd M, Wicklein EM, Eymard B, Duboc D, Penisson‐Besnier I, Cuisset JM, Ferrer X, Desguerre I, Lacombe D, Bushby K, Pollitt C, Toniolo D, Fardeau M, Schwartz K, Muntoni F (2000) Clinical and molecular genetic spectrum of autosomal dominant Emery‐Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 48:170–180. - PubMed
-
- Bonne G, Ben Yaou RB, Beroud C, Boriani G, Brown S, De Visser M, Duboc D, Ellis J, Hausmanowa‐Petrusewicz I, Lattanzi G, Merlini L, Morris G, Muntoni F, Opolski G, Pinto YM, Sangiuolo F, Toniolo D, Trembath R, Van Berlo JH, Van der Kooi AJ, Wehnert M (2003) 108th ENMC International Workshop, 3rd Workshop of the MYO‐CLUSTER project EUROMEN, 7th International Emery‐Dreifuss Muscular Dystrophy (EDMD) Workshop, 13–15 September 2002, Naarden, The Netherlands. Neuromuscul Disord 13:508–515. - PubMed
-
- Boriani G, Gallina M, Merlini L, Bonne G, Toniolo D, Amati S, Biffi M, Martignani C, Frabetti L, Bonvicini M, Rapezzi C, Branzi A (2003) Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery‐Dreifuss muscular dystrophy: a long‐term longitudinal study. Stroke 2003:901–908. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous